Advertisement

Spring 2014 Vol. 04 Issue 01

Advertisement

From the AACR

  • Targeting KRAS

    After decades of failed efforts to target the elusive KRAS, encouraging data suggest KRAS could finally be dethroned from the “undruggable” category.

  • New FDA Approval

    The U.S. Food and Drug Administration has approved an ovarian cancer treatment based on new biomarker.

  • Advances in Lung Cancer Research and Treatment

    Lung cancer—one of the most commonly diagnosed cancers in the United States—is an area of intense research and clinical development.

Advertisement

Video

Follow My Lead

Advertisement

social media

donate to the AACR